ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.10, sa.3, ss.253-259, 2010 (SCI-Expanded)
Objective: Our aim was to investigate the effects of serotonin, which is a severe vasoconstrictor agent, on the occurrence of no-reflow phenomenon.